Clinical Trial Update: The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY) [NA]

View source ↗

Summary

This entry provides an update on the ongoing clinical trial NCT05820087 evaluating the Edison system from HistoSonics for treating primary solid renal tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: HistoSonics, Inc. | Conditions: Renal Cancer, Tumor, Solid | NA | Status: ACTIVE_NOT_RECRUITING